HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Obliterative bronchiolitis in lung allografts removed at retransplant for intractable airway problems.

AbstractBACKGROUND AND OBJECTIVE:
The role of large airway ischaemia, with resultant airway narrowing, in the development of post-lung transplant bronchiolitis obliterans has not been defined. A determination of clinical bronchiolitis obliterans syndrome (BOS), which is defined as a decline in FEV(1) from a stable post-transplant baseline, is difficult in the setting of airway complications. The aim of this study was to assess the evidence for histological bronchiolitis obliterans in lung allografts removed during retransplantation for severe recurrent airway narrowing.
METHODS:
Case records and histological findings in allograft lungs removed at retransplantation were retrospectively reviewed.
RESULTS:
Five lung transplant recipients, who had undergone retransplantation because of severe recalcitrant airway stenosis, were identified. In each case, explant allograft lung pathology revealed evidence of bronchiolitis obliterans.
CONCLUSIONS:
There is a possible link between airway ischaemia, large airway stenosis and the development of bronchiolitis obliterans, which is the most common cause of death in lung transplant recipients after the first year. These findings may provide an impetus for evaluation of the role of bronchial artery revascularization techniques in the prevention of bronchiolitis obliterans.
AuthorsOlufemi Akindipe, Sebastian Fernandez-Bussy, Michael Jantz, Li Lu, Amy Deem, Wendy Swafford, Edward Staples, Maher Baz
JournalRespirology (Carlton, Vic.) (Respirology) Vol. 14 Issue 4 Pg. 601-5 (May 2009) ISSN: 1440-1843 [Electronic] Australia
PMID19383111 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Bronchiolitis Obliterans (etiology, pathology, surgery)
  • Female
  • Graft Rejection (etiology, pathology, surgery)
  • Humans
  • Lung Diseases, Interstitial (etiology, pathology, surgery)
  • Lung Transplantation (adverse effects)
  • Male
  • Middle Aged
  • Reoperation
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: